NCT05935085 · Interventional trial
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
Overall registry status Terminated
Phase 2
Conditions Atopic Dermatitis Eczema
Delaware Valley sites
- AnaptysBio Investigative Site 10-145 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory